Product Images Lacosamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Lacosamide NDC 25021-791 by Sagent Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - lac04 0002 01

Chemical Structure - lac04 0002 01

Figure 1 - lac04 0002 02

Figure 1 - lac04 0002 02

This appears to be a chart or a table showing some percentage values and medications used for seizure reduction. The text is not entirely readable and some parts of it are symbols or non-English characters. Therefore, it is not possible to generate a useful description.*

Figure 2 - lac04 0002 03

Figure 2 - lac04 0002 03

This is a chart displaying the responder rate (equal to or greater) for patients taking placebo and lacosamide at different dosages. The data shown includes the number of patients in each group (N) and the percent of patients who experienced improvement or worsening. The chart shows that higher dosages of lacosamide generally resulted in higher responder rates.*

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label - lac04 0002 04

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label - lac04 0002 04

The text contains information regarding a drug with code number GO/DRUGS/557. The drug is an injection with the name Lacosam, and it is listed as USP with a concentration of 200 mg per 20 mL. The NDC number for the drug is 25021-791-20. Other characters and numbers seem unrelated and do not provide additional useful information.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.